spacer
spacer
Go to PDB code: 
protein ligands links
Hydrolase PDB id
1b1i
Jmol
Contents
Protein chain
123 a.a. *
Ligands
CIT
Waters ×53
* Residue conservation analysis
PDB id:
1b1i
Name: Hydrolase
Title: Crystal structure of human angiogenin
Structure: Hydrolase angiogenin. Chain: a. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.80Å     R-factor:   0.222     R-free:   0.273
Authors: D.D.Leonidas,K.R.Acharya
Key ref:
D.D.Leonidas et al. (1999). Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J Mol Biol, 285, 1209-1233. PubMed id: 9918722 DOI: 10.1006/jmbi.1998.2378
Date:
20-Nov-98     Release date:   02-Apr-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P03950  (ANGI_HUMAN) -  Angiogenin
Seq:
Struc:
147 a.a.
123 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   8 terms 
  Biological process     metabolic process   24 terms 
  Biochemical function     nucleic acid binding     14 terms  

 

 
DOI no: 10.1006/jmbi.1998.2378 J Mol Biol 285:1209-1233 (1999)
PubMed id: 9918722  
 
 
Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
D.D.Leonidas, R.Shapiro, S.C.Allen, G.V.Subbarao, K.Veluraja, K.R.Acharya.
 
  ABSTRACT  
 
Human angiogenin (Ang), an unusual member of the pancreatic RNase superfamily, is a potent inducer of angiogenesis in vivo. Its ribonucleolytic activity is weak (10(4) to 10(6)-fold lower than that of bovine RNase A), but nonetheless seems to be essential for biological function. Ang has been implicated in the establishment of a wide range of human tumours and has therefore emerged as an important target for the design of new anti-cancer compounds. We report high-resolution crystal structures for native Ang in two different forms (Pyr1 at 1.8 A and Met-1 at 2.0 A resolution) and for two active-site variants, K40Q and H13A, at 2.0 A resolution. The native structures, together with earlier mutational and biochemical data, provide a basis for understanding the unique functional properties of this molecule. The major structural features that underlie the weakness of angiogenin's RNase activity include: (i) the obstruction of the pyrimidine-binding site by Gln117; (ii) the existence of a hydrogen bond between Thr44 and Thr80 that further suppresses the effectiveness of the pyrimidine site; (iii) the absence of a counterpart for the His119-Asp121 hydrogen bond that potentiates catalysis in RNase A (the corresponding aspartate in Ang, Asp116, has been recruited to stabilise the blockage of the pyrimidine site); and (iv) the absence of any precise structural counterparts for two important purine-binding residues of RNase A. Analysis of the native structures has revealed details of the cell-binding region and nuclear localisation signal of Ang that are critical for angiogenicity. The cell-binding site differs dramatically from the corresponding regions of RNase A and two other homologues, eosinophil-derived neurotoxin and onconase, all of which lack angiogenic activity. Determination of the structures of the catalytically inactive variants K40Q and H13A has now allowed a rigorous assessment of the relationship between the ribonucleolytic and biological activities of Ang. No significant change outside the enzymatic active site was observed in K40Q, establishing that the loss of angiogenic activity for this derivative is directly attributable to disruption of the catalytic apparatus. The H13A structure shows some changes beyond the ribonucleolytic site, but sites involved in cell-binding and nuclear translocation are essentially unaffected by the amino acid replacement.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. A representation of the Ang structure. The disulphide bonds are shown in ball-and-stick representation. The inset presents the details of the Ang ribonucleolytic active site including water molecules (in blue). The amino acid residues are shown in standard colour. Broken lines represent hydrogen bonds.
Figure 10.
Figure 10. Stereo view of the superimposed C a back- bones of native Ang (Pyr1 form, black) onto those of K40Q (green) and H13A (red).
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (1999, 285, 1209-1233) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19158252 S.Sadagopan, N.Sharma-Walia, M.V.Veettil, V.Bottero, R.Levine, R.J.Vart, and B.Chandran (2009).
Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
  J Virol, 83, 3342-3364.  
18508078 K.Kazakou, D.E.Holloway, S.H.Prior, V.Subramanian, and K.R.Acharya (2008).
Ribonuclease A homologues of the zebrafish: polymorphism, crystal structures of two representatives and their evolutionary implications.
  J Mol Biol, 380, 206-222.
PDB codes: 2vq8 2vq9
17559675 D.Dell'Orco, P.G.De Benedetti, and F.Fanelli (2007).
In silico screening of mutational effects on enzyme-proteic inhibitor affinity: a docking-based approach.
  BMC Struct Biol, 7, 37.  
17883850 D.S.Osorio, A.Antunes, and M.J.Ramos (2007).
Structural and functional implications of positive selection at the primate angiogenin gene.
  BMC Evol Biol, 7, 167.  
17460791 E.Boix, and M.V.Nogués (2007).
Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.
  Mol Biosyst, 3, 317-335.  
16433931 H.T.Chang, T.W.Pai, T.C.Fan, B.H.Su, P.C.Wu, C.Y.Tang, C.T.Chang, S.H.Liu, and M.D.Chang (2006).
A reinforced merging methodology for mapping unique peptide motifs in members of protein families.
  BMC Bioinformatics, 7, 38.  
16301790 D.E.Holloway, G.B.Chavali, M.C.Hares, V.Subramanian, and K.R.Acharya (2005).
Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.
  Acta Crystallogr D Biol Crystallogr, 61, 1568-1578.
PDB codes: 2bwk 2bwl
15146489 B.S.Sanjeev, and S.Vishveshwara (2004).
Protein-water interactions in ribonuclease A and angiogenin: a molecular dynamics study.
  Proteins, 55, 915-923.  
12945053 A.Merlino, L.Vitagliano, M.A.Ceruso, and L.Mazzarella (2003).
Subtle functional collective motions in pancreatic-like ribonucleases: from ribonuclease A to angiogenin.
  Proteins, 53, 101-110.  
  12842050 G.B.Chavali, A.C.Papageorgiou, K.A.Olson, J.W.Fett, G.Hu, R.Shapiro, and K.R.Acharya (2003).
The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody.
  Structure, 11, 875-885.
PDB code: 1h0d
12471601 J.L.Jenkins, R.Y.Kao, and R.Shapiro (2003).
Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
  Proteins, 50, 81-93.  
11876642 G.J.Swaminathan, D.E.Holloway, K.Veluraja, and K.R.Acharya (2002).
Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin.
  Biochemistry, 41, 3341-3352.
PDB code: 1gqv
12118120 R.Y.Kao, J.L.Jenkins, K.A.Olson, M.E.Key, J.W.Fett, and R.Shapiro (2002).
A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.
  Proc Natl Acad Sci U S A, 99, 10066-10071.  
11468363 D.D.Leonidas, G.B.Chavali, A.M.Jardine, S.Li, R.Shapiro, and K.R.Acharya (2001).
Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.
  Protein Sci, 10, 1669-1676.
PDB codes: 1h52 1h53 1hby
11536357 M.S.Madhusudhan, B.S.Sanjeev, and S.Vishveshwara (2001).
Computer modeling and molecular dynamics simulations of ligand bound complexes of bovine angiogenin: dinucleotide topology at the active site of RNase a family proteins.
  Proteins, 45, 30-39.  
11093266 M.S.Madhusudhan, and S.Vishveshwara (2001).
Computer modeling of human angiogenin-dinucleotide substrate interaction.
  Proteins, 42, 125-135.  
11296285 N.E.Robinson, and A.B.Robinson (2001).
Prediction of protein deamidation rates from primary and three-dimensional structure.
  Proc Natl Acad Sci U S A, 98, 4367-4372.  
10880568 K.Tomita, T.Ogawa, T.Uozumi, K.Watanabe, and H.Masaki (2000).
A cytotoxic ribonuclease which specifically cleaves four isoaccepting arginine tRNAs at their anticodon loops.
  Proc Natl Acad Sci U S A, 97, 8278-8283.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.